FIELD: medicine, virology. SUBSTANCE: method involves administration of genetic engineering alpha-2-interferon - alphaferon at doses 100000-200000 IU/kg body mass/day by internal route depending on age and at simultaneous administration of alpha-tocopherol at age doses for 3-5 days. EFFECT: enhanced effectiveness of treatment.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING VIRAL DIARRHEA | 1992 |
|
RU2014844C1 |
METHOD OF TREATMENT OF CHILDREN WITH INFECTIOUS MONONUCLEOSIS | 1998 |
|
RU2150955C1 |
METHOD OF TREATMENT OF CHILDREN WITH PNEUMOCYSTIC INFECTION | 1995 |
|
RU2122861C1 |
METHOD OF TREATMENT OF AN ACUTE STENOSED LARYNGOTRACHEITIS IN CHILDREN | 1993 |
|
RU2097062C1 |
METHOD OF TREATMENT OF CHILDREN OF FIRST YEAR LIFE WITH ACUTE RESPIRATORY VIRAL DISEASE | 2001 |
|
RU2195315C2 |
METHOD OF TREATMENT OF PATIENTS WITH DIPHTHERIA TOXIC FORMS | 1996 |
|
RU2137497C1 |
METHOD OF PERTUSSIS TREATMENT IN CHILDREN | 1997 |
|
RU2145872C1 |
METHOD FOR TREATMENT OF GASTROENTEROCOLITIS | 1994 |
|
RU2099072C1 |
METHOD FOR TREATING CHRONIC HEPATITIS IN CHILDREN | 1999 |
|
RU2149019C1 |
METHOD OF IMMUNOCORRECTION IN CHILDREN | 1999 |
|
RU2185828C2 |
Authors
Dates
1998-02-10—Published
1994-06-28—Filed